Minnesota 2025-2026 Regular Session

Minnesota Senate Bill SF2176 Latest Draft

Bill / Introduced Version Filed 03/04/2025

                            1.1	A bill for an act​
1.2 relating to health care; requiring that an enrollee receive any rebates and discounts​
1.3 accrued directly or indirectly to health carriers; proposing coding for new law in​
1.4 Minnesota Statutes, chapter 62A.​
1.5BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:​
1.6 Section 1. [62A.3096] COST-SHARING REDUCTIONS AT POINT OF SALE.​
1.7 Subdivision 1.Definitions.(a) For purposes of this section, the following terms have​
1.8the meanings given.​
1.9 (b) "Defined cost-sharing" means a deductible or coinsurance amount imposed on an​
1.10enrollee for a covered prescription drug under the terms of the enrollee's health plan.​
1.11 (c) "Health carrier" has the meaning given in section 62A.011, subdivision 2. Health​
1.12carrier includes a pharmacy benefit manager as defined in section 62W.02, subdivision 15,​
1.13with respect to the pharmacy benefit management services provided on behalf of a health​
1.14carrier.​
1.15 (d) "Price protection rebate" means a negotiated price concession that accrues directly​
1.16or indirectly to the health carrier, or other party on behalf of the health carrier, in the event​
1.17the wholesale acquisition cost of a drug increases above a specified threshold.​
1.18 (e) "Rebate" means:​
1.19 (1) negotiated price concessions, including but not limited to base price concessions,​
1.20whether described as a rebate or otherwise, and reasonable estimates of any price protection​
1.21rebates and performance-based price concessions that may accrue directly or indirectly to​
1​Section 1.​
25-02751 as introduced​02/07/25 REVISOR RSI/AC​
SENATE​
STATE OF MINNESOTA​
S.F. No. 2176​NINETY-FOURTH SESSION​
(SENATE AUTHORS: NELSON)​
OFFICIAL STATUS​D-PG​DATE​
Introduction and first reading​03/06/2025​
Referred to Commerce and Consumer Protection​ 2.1the health carrier during the coverage year from a manufacturer, dispensing pharmacy, or​
2.2other party in connection with dispensing or administering a prescription drug; and​
2.3 (2) reasonable estimates of any negotiated prices, concessions, fees, and other​
2.4administrative costs that are passed through to the health carrier and serve to reduce the​
2.5health carrier's liabilities for a prescription drug.​
2.6 Subd. 2.Decrease in cost-sharing.(a) An enrollee's defined cost-sharing for each​
2.7prescription drug must be calculated at the point of sale based on a price that is reduced by​
2.8an amount equal to 100 percent of all rebates received or to be received in connection with​
2.9dispensing or administering the prescription drug.​
2.10 (b) Nothing in this section precludes a health carrier from decreasing an enrollee's defined​
2.11cost-sharing by an amount greater than is required under this subdivision.​
2.12 Subd. 3.Confidentiality.(a) When complying with this section, a health carrier or the​
2.13health carrier's agents must not publish or otherwise reveal information regarding the actual​
2.14amount of rebates a health carrier receives on a product, therapeutic class of products,​
2.15manufacturer-specific basis, or pharmacy-specific basis.​
2.16 (b) Rebate information is protected as a trade secret, is not a public record under chapter​
2.1713, and must not be disclosed:​
2.18 (1) directly;​
2.19 (2) indirectly;​
2.20 (3) in a manner that may identify an individual product, therapeutic class of products,​
2.21or manufacturer; or​
2.22 (4) in a manner that has the potential to compromise the financial, competitive, or​
2.23proprietary nature of the information.​
2.24 (c) A health carrier must impose the confidentiality protections of this section on any​
2.25vendor or downstream third party that performs health care or administrative services on​
2.26behalf of the health carrier that may receive or have access to rebate information.​
2.27 Subd. 4.Enforcement.A health carrier or pharmacy benefit manager that fails to comply​
2.28with this section may be subject to sanctions under the appropriate chapters regulating the​
2.29health carrier or pharmacy benefit manager, including civil penalties and suspension or​
2.30revocation of the health carrier's or pharmacy benefit manager's license.​
2​Section 1.​
25-02751 as introduced​02/07/25 REVISOR RSI/AC​